B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+4.66%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.98B
AUM Growth
–
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
56.69%
Top 10 Holdings %
Top 10 Hldgs %
33.01%
Holding
88
New
63
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Glaukos
GKOS
|
$72.6M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$71.5M |
| 3 |
Biogen
BIIB
|
$69.9M |
| 4 |
Vaxcyte
PCVX
|
$65.3M |
| 5 |
Natera
NTRA
|
$65.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 56.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Glaukos
GKOS
$5.5B
| $72.6M | 2.43% | +1,661,851 | New | +$72.6M |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $71.5M | 2.4% | +3,341,300 | New | +$71.5M |
|
|
3
Biogen
BIIB
$19.4B
| $69.9M | 2.34% | +252,542 | New | +$69.9M |
|
|
4
Vaxcyte
PCVX
$4B
| $65.3M | 2.19% | +1,362,278 | New | +$65.3M |
|
|
5
Natera
NTRA
$23.1B
| $65.1M | 2.18% | +1,621,012 | New | +$65.1M |
|
6
Crinetics Pharmaceuticals
CRNX
$2.92B
| $63.5M | 2.13% | +3,469,674 | New | +$63.5M |
|
7
Xenon Pharmaceuticals
XENE
$2.98B
| $61M | 2.05% | +1,548,110 | New | +$61M |
|
8
Intuitive Surgical
ISRG
$170B
| $59.2M | 1.98% | +223,120 | New | +$59.2M |
|
|
DCPH
9
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $53.6M | 1.8% | +3,271,513 | New | +$53.6M |
|
|
NVRO
10
DELISTED
NEVRO CORP.
NVRO
| $47.2M | 1.58% | +1,192,298 | New | +$47.2M |
|
11
iRhythm Technologies
IRTC
$5.46B
| $46.6M | 1.56% | +497,667 | New | +$46.6M |
|
12
Align Technology
ALGN
$10.3B
| $46.4M | 1.55% | +219,930 | New | +$46.4M |
|
13
Outset Medical
OM
$247M
| $44M | 1.47% | +1,704,552 | New | +$44M |
|
14
OrthoPediatrics
KIDS
$536M
| $41.5M | 1.39% | +1,044,699 | New | +$41.5M |
|
15
Aclaris Therapeutics
ACRS
$209M
| $37.7M | 1.26% | +2,393,985 | New | +$37.7M |
|
16
Penumbra
PEN
$10.6B
| $36.2M | 1.21% | +162,828 | New | +$36.2M |
|
17
Amgen
AMGN
$155B
| $34.4M | 1.15% | +131,100 | New | +$34.4M |
|
|
BLU
18
DELISTED
BELLUS Health Inc.
BLU
| $33.8M | 1.13% | +4,112,494 | New | +$33.8M |
|
19
Legend Biotech
LEGN
$6.41B
| $32.9M | 1.1% | +658,101 | New | +$32.9M |
|
20
Syndax Pharmaceuticals
SNDX
$1.41B
| $31.6M | 1.06% | +1,242,802 | New | +$31.6M |
|
21
Merus
MRUS
$4.98B
| $30.9M | 1.04% | +1,998,084 | New | +$30.9M |
|
22
Travere Therapeutics
TVTX
$1.56B
| $30.6M | 1.03% | +1,455,585 | New | +$30.6M |
|
23
Krystal Biotech
KRYS
$4.27B
| $28.4M | 0.95% | +358,056 | New | +$28.4M |
|
24
HilleVax
HLVX
$105M
| $27.1M | 0.91% | +1,620,216 | New | +$27.1M |
|
25
Day One Biopharmaceuticals
DAWN
$769M
| $26.8M | 0.9% | +1,246,539 | New | +$26.8M |
|